Trial Profile
Endeavor Zotarolimus Eluting Stent Post Marketing Surveillance in Japan
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2013
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
- Focus Therapeutic Use
- 16 Feb 2013 New trial record